Front page

The European giant will not rule out a dedicated life sciences growth fund in the medium term, co-head of global healthcare Michael Bauer told PEI.

The alternatives firm could seek between $8bn and $10bn for Carlyle Asia Partners VI, PEI understands.

The biggest listed alternatives firms have more than $550bn in unspent capital, fuelling fiercer competition and higher entry prices.

ILPA has 'adopted in full' the PRI's approach in the latest update to its template due diligence questionnaire,

The growth investor gathered $7.8bn for its sixth flagship fund, and a further $16bn for its managed accounts and evergreen programme.

Recruitment could be the biggest challenge facing family offices, Professor Heinrich Liechtenstein of IESE Business School told delegates at the Cyberport Venture Capital Forum in Hong Kong.

The firm expects to more than double capital raised from the private wealth channel in the near term, said co-chief executive Scott Nuttall on the third-quarter earnings call.

The alternatives giant's plans come as firms including Ares Management and Apollo Global Management make a concerted push into raising capital from wealthy individuals.

65 Equity Partners intends to raise third-party capital in future vintages, Temasek president Tan Chong Lee says.

Though it is rare for a buyout shop to go public in Korea, STIC Investments will join a handful of listed venture capital firms in the country.